Mark R. Green
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Oncology top 0.2%
- Lung Cancer Research Studies
Papers in
- Oncology 82
- Lung Cancer Research Studies 59
- Cancer Treatment and Pharmacology 7
-
- Lung Cancer Treatments and Mutations 73
- Lung Cancer Diagnosis and Treatment 44
- Occupational and environmental lung diseases 15
- Pleural and Pulmonary Diseases 10
- Co-authors
- James E. HerndonKathleen J. PropertEverett E. VokesMichael C. PerryDorothy WatsonDavid J. SugarbakerWalter L. EatonRobert W. Carey
- Journals
- Lung Cancer (25 papers)Cancer (16 papers)Journal of Clinical Oncology (15 papers)Journal of Thoracic Oncology (13 papers)Clinical Lung Cancer (8 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark R. Green
128 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pulmonary and Respiratory Medicine 7.3k
- Oncology 5.0k
- Otorhinolaryngology 474
- Microbiology 51
- Radiation 548
Countries citing papers authored by Mark R. Green
This map shows the geographic impact of Mark R. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Green more than expected).
Fields of papers citing papers by Mark R. Green
This network shows the impact of papers produced by Mark R. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Green. The network helps show where Mark R. Green may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark R. Green, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 21 | |
| 2 | 2009 | 4 | |
| 3 | 2009 | 11 | |
| 4 | Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups Hit paper breakdown → | 2008 | 690 |
| 5 | 2008 | 15 | |
| 6 | 2008 | 10 | |
| 7 | 2006 | 37 | |
| 8 | 2004 | 116 | |
| 9 | 2003 | 54 | |
| 10 | 1999 | 14 | |
| 11 | 1998 | 25 | |
| 12 | 1997 | 3 | |
| 13 | Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062). | 1997 | 23 |
| 14 | 1995 | 9 | |
| 15 | 1994 | 3 | |
| 16 | 1993 | 13 | |
| 17 | 1993 | 9 | |
| 18 | 1992 | 12 | |
| 19 | 1990 | 17 | |
| 20 | Phase I trials of thymosin fraction 5 and thymosin α1 | 1982 | 6 |
About Mark R. Green
Mark R. Green is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Epidemiology and Hepatology, having authored 131 papers that have together received 9.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (73 papers), Lung Cancer Research Studies (59 papers), Lung Cancer Diagnosis and Treatment (44 papers), Neuroendocrine Tumor Research Advances (28 papers), Cancer therapeutics and mechanisms (24 papers), Occupational and environmental lung diseases (15 papers), Pleural and Pulmonary Diseases (10 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.3k citations), Oncology (5.0k citations), Otorhinolaryngology (474 citations), Microbiology (51 citations) and Radiation (548 citations). Mark R. Green has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include James E. Herndon, Kathleen J. Propert, Everett E. Vokes, Michael C. Perry, Dorothy Watson, David J. Sugarbaker, Walter L. Eaton, Robert W. Carey, Stephen L. Seagren and Antonius A. Miller. Their work appears in journals such as Lung Cancer, Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.